Advisors Asset Management Inc. Acquires 27,752 Shares of Synopsys, Inc. $SNPS

Advisors Asset Management Inc. acquired a new position in Synopsys, Inc. (NASDAQ:SNPS – Free Report) in the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The institutional investor acquired 27,752 shares of the semiconductor company’s stock, valued at approximately $12,070,000.

Other hedge funds have also made changes to their positions in the company. Elevation Wealth Partners LLC lifted its position in Synopsys by 96.4% during the 2nd quarter. Elevation Wealth Partners LLC now owns 55 shares of the semiconductor company’s stock worth $25,000 after acquiring an additional 27 shares in the last quarter. North Dakota State Investment Board raised its stake in shares of Synopsys by 0.5% during the third quarter. North Dakota State Investment Board now owns 5,706 shares of the semiconductor company’s stock valued at $2,482,000 after purchasing an additional 29 shares during the period. Oak Grove Capital LLC lifted its position in shares of Synopsys by 1.1% during the third quarter. Oak Grove Capital LLC now owns 2,898 shares of the semiconductor company’s stock worth $1,260,000 after purchasing an additional 32 shares in the last quarter. Kintegral Advisory LLC increased its stake in Synopsys by 0.6% during the 3rd quarter. Kintegral Advisory LLC now owns 5,812 shares of the semiconductor company’s stock worth $2,528,000 after buying an additional 32 shares during the period. Finally, Centaurus Financial Inc. lifted its holdings in Synopsys by 2.6% in the 1st quarter. Centaurus Financial Inc. now owns 1,434 shares of the semiconductor company’s stock worth $569,000 after buying an additional 36 shares in the last quarter. Hedge funds and other institutional investors own 85.47% of the company’s stock.

Insiders Place Their Bets

In other news, CFO Sudhindra Kankanwadi sold 9,170 shares of the firm’s stock in a transaction on Tuesday, October 6th. The stock was sold at an average price of $500.00, for a total transaction of $4,585,000.00. Following the transaction, the chief financial officer directly owned 22,717 shares of the company’s stock, valued at approximately $11,358,500. This trade represents a 28.76% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CEO Sassine Ghazi sold 14,604 shares of Synopsys stock in a transaction dated Tuesday, September 15th. The shares were sold at an average price of $374.88, for a total transaction of $5,474,747.52. Following the sale, the chief executive officer owned 76,865 shares in the company, valued at approximately $28,815,151.20. This represents a 15.97% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. In the last ninety days, insiders have sold 117,163 shares of company stock valued at $51,366,457. Corporate insiders own 0.56% of the company’s stock.

Synopsys Price Performance

SNPS opened at $396.55 on Friday. The company has a quick ratio of 1.24, a current ratio of 1.34 and a debt-to-equity ratio of 0.29. The company’s 50-day moving average price is $448.46 and its 200 day moving average price is $440.14. Synopsys, Inc. has a fifty-two week low of $362.55 and a fifty-two week high of $539.48. The firm has a market cap of $76.00 billion, a price-to-earnings ratio of 70.06, a price-to-earnings-growth ratio of 1.26 and a beta of 1.18.

Synopsys (NASDAQ:SNPS – Get Free Report) last issued its earnings results on Wednesday, August 26th. The semiconductor company reported $3.91 EPS for the quarter, beating analysts’ consensus estimates of $3.67 by $0.24. Synopsys had a return on equity of 6.24% and a net margin of 11.43%. The company had revenue of $2.48 billion during the quarter, compared to the consensus estimate of $2.44 billion. During the same period in the previous year, the firm posted $3.39 earnings per share. Synopsys’s quarterly revenue was up 42.4% compared to the same quarter last year. Synopsys has set its Q4 2026 guidance at 4.100-4.160 EPS and its FY 2026 guidance at 15.040-15.100 EPS. As a group, sell-side analysts expect that Synopsys, Inc. will post 11.01 earnings per share for the current year.

Synopsys declared that its board has initiated a stock repurchase plan on Monday, October 5th that authorizes the company to repurchase $1 billion in shares. This repurchase authorization authorizes the semiconductor company to purchase up to 1.1% of its shares through open market purchases. Stock repurchase plans are usually an indication that the company’s board believes its stock is undervalued.

Analyst Ratings Changes

A number of equities analysts have commented on SNPS shares. Weiss Ratings lowered shares of Synopsys from a “hold (c)” rating to a “hold (c-)” rating in a report on Friday, September 11th. Robert W. Baird upgraded Synopsys from a “neutral” rating to an “outperform” rating and raised their target price for the company from $558.00 to $560.00 in a research note on Thursday, August 27th. JPMorgan Chase & Co. dropped their price objective on Synopsys from $650.00 to $600.00 in a report on Thursday, August 27th. Bank of America upped their target price on Synopsys from $500.00 to $600.00 in a research report on Thursday, October 1st. Finally, Roth Capital raised Synopsys to a “buy” rating in a research report on Friday, September 25th. One equities research analyst has rated the stock with a Strong Buy rating, twenty-two have given a Buy rating and three have given a Hold rating to the company. According to MarketBeat, Synopsys has a consensus rating of “Moderate Buy” and an average price target of $577.71.

View Our Latest Report on Synopsys

Synopsys News Roundup

Investors following SNPS have been watching these news items:

  • Positive Sentiment: Barclays initiated coverage with an Overweight rating and a $640 price target, citing Synopsys’ leadership in electronic design automation, AI-related R&D tailwinds and long-term free-cash-flow potential. The bullish call was accompanied by a gain in Thursday trading. Barclays starts Synopsys at Overweight
  • Positive Sentiment: Synopsys-backed Ansys is supporting an integration between Instem’s toxicology tools and its simulation platform, extending the company’s reach into packaging safety and materials-risk workflows. This could broaden use of its simulation ecosystem, though the financial impact is not specified. Synopsys broadens platform reach
  • Neutral Sentiment: Synopsys is described as having stronger forward growth and a lower forward valuation multiple than Cadence, but Cadence is credited with a stronger balance sheet and returns on capital. Synopsys vs. Cadence

Synopsys Company Profile

(Free Report)

Synopsys, Inc. develops software, semiconductor intellectual property (IP) and services used to design and verify electronic systems. Its electronic design automation (EDA) tools help customers create, simulate, test and validate chips and other complex electronic products, while its IP portfolio provides reusable building blocks for semiconductor designs. The company also offers software security and quality tools that help developers identify vulnerabilities and assess applications throughout the software development process.

See Also

Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS – Free Report).

Institutional Ownership by Quarter for Synopsys (NASDAQ:SNPS)

Receive News & Ratings for Synopsys Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Synopsys and related companies with MarketBeat.com's FREE daily email newsletter.